Document is current
Any future updates will be listed below
-
Authors
Xiu, Xin
Chen, Sijia
Liu, Yumei
Sun, Bo
Li, Hulun
Zhang, Sifan
Yang, Xixi
Wei, Yu
Peng, Xichen
Wang, Yan
Wang, Yanping
Wu, Junfeng
Zhang, Yao
Mu, Lili
Kong, Qingfei
Liu, Xijun https://orcid.org/0009-0009-2245-6387
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Heilongjiang Province (LH2022H004)
National Natural Science Foundation of China (82371821, 82271845)
Special Project of Traditional Chinese Medicine in Heilongjiang Province of China (ZYW2023-132)
- License Information
-
More Information
Article History
Received: 5 December 2024
Accepted: 16 May 2025
First Online: 9 June 2025
Declarations
:
: This study does not involve clinical experiments. All animal handling and experimental procedures were performed in accordance with the guidelines of the Care and Use of Laboratory Animals published by the China National Institute of Health. Animal ethics review was approved by the Medical Ethics Committee of Harbin Medical University. Approved Project Title: The role and mechanism of BMSCs combined with miRNA in the treatment of multiple sclerosis. Approval number: HMUIRB20180010. Date of approval: 29 May 2018. 293T used in this study were purchased from GeneCopoeia, the original source (GeneCopoeia) has confirmed that there was initial ethical approval for collection of human cells, and that the donors had signed informed consent.
: Not applicable.
: The authors declare that they have no competing interests.
